Supreme Court Rejects Plea Alleging Side Effects Of COVID-19 Vaccines

New Delhi:  The Supreme Court of India on Monday dismissed a petition alleging that COVID-19 vaccines caused severe side effects, including blood clotting, calling the plea as an attempt to create unnecessary alarm.

A bench led by Chief Justice DY Chandrachud, along with Justices JB Pardiwala and Manoj Misra, declined to entertain the petition, stating that it lacked merit. “We don’t want to rake this up. This is just to create a sensation,” remarked the bench, questioning the usefulness of the petition.

The court further highlighted the broader implications, suggesting that public health efforts might have been compromised if people had refrained from taking the vaccine.

During the proceedings, the court directly questioned the petitioner’s lawyer on whether he had taken the vaccine. After confirming that he had received the vaccine and experienced no side effects, the bench emphasized the lack of merit in the case.

The petition was filed by Priya Mishra and others, who sought to challenge the alleged adverse effects of the COVID-19 vaccination drive.

Case Details: PRIYA MISHRA AND ANR. vs UNION OF INDIA AND ORS., Diary No. 22945-2024

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre